Skip to Main Content

Paper Details

Transcriptome analysis reveals overlap in fusion genes in a phase I clinical cohort of TNBC and HGSOC patients treated with buparlisib and olaparib.
J Cancer Res Clin Oncol
5
2020
FOXP1, FOXP1 fusion, FOXP1 fusions, HGSOC, MALAT1, MUC16, PARP, PI3K, PURPOSE Fusion genes, TNBC, WWOX, XIST, buparlisib, female cancers, fusion gene, fusion genes, high-grade serous ovarian cancer, long non-coding RNA MALAT1, olaparib, oncogenes, patient, patients, triple-negative breast cancer, tumor
Author NameAffiliation
Ioannis S VlachosHarvard Medical School
Ioannis S VlachosBeth Israel Deaconess Medical Center
Ioannis S VlachosBroad Institute of MIT and Harvard
Ioannis S VlachosHarvard Medical School
Ioannis S VlachosBeth Israel Deaconess Medical Center
Ioannis S VlachosBroad Institute of MIT and Harvard
Gerburg M WulfBeth Israel Deaconess Medical Center
Gerburg M WulfHarvard Medical School
  • 1 - 8

Datasets

Release 1.2